Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. SCHERING-PLOUGH
  6. Summary
    SPL   US8066051017

SCHERING-PLOUGH

(SPL)
 SummaryNewsCompany 
Company
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about SCHERING-PLOUGH
2009SCHERING-PLOUGH : Announces Sponsorship of Rabies-Control Projects in India
PR
2009SCHERING-PLOUGH : Investigational Sublingual Allergy Immunotherapy Tablet Meets ..
PR
2009SCHERING-PLOUGH : U.S. Food and Drug Administration Issues Complete Response Let..
PR
2009SCHERING-PLOUGH : Standard & Poor's Announces Changes to U.S. Indices
PR
2009SCHERING-PLOUGH : Reports Financial Results for 2009 Third Quarter
PR
2009SCHERING-PLOUGH : Nobilon Advances Intranasal Seasonal Influenza Vaccine Into Pr..
PR
2009SCHERING-PLOUGH : Schedules Conference Call Webcast For 2009 Third Quarter Earni..
PR
2009SCHERING-PLOUGH : SIMPONI(TM) (golimumab) Receives European Approval as Once-Mon..
PR
2009SCHERING-PLOUGH : Declares Quarterly Dividends on Common Shares and Mandatory Co..
PR
2009SCHERING-PLOUGH : Reports Long-Term Vicriviroc Data From Phase II Open-Label Ext..
PR
2009SCHERING-PLOUGH : Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophren..
PR
2009SCHERING-PLOUGH : New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Thro..
PR
2009SCHERING-PLOUGH : Announces Two European Filings
PR
2009SCHERING-PLOUGH : ANNOUNCES FDA APPROVAL OF SAPHRIS(R) (asenapine): for acute tr..
PR
2009SCHERING-PLOUGH : Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (a..
PR
More news
News in other languages on SCHERING-PLOUGH
2009SCHERING-PLOUGH : troisième trimestre en ligne avec les attentes
2009SCHERING-PLOUGH : BPA ajusté stable au 3e trimestre.
2009SCHERING-PLOUGH : nouveaux essais sur un vaccin anti-grippe.
2009SCHERING-PLOUGH : double approbation de la FDA pour Saphris.
2009SCHERING-PLOUGH : accroît fortement ses résultats.
More news
Analyst Recommendations on SCHERING-PLOUGH
More recommendations
Sector and Competitors
1st jan.Capi. (M$)
SCHERING-PLOUGH0
CSL LIMITED9.25%102 521
WUXI BIOLOGICS (CAYMAN) INC.19.75%67 077
SAMSUNG BIOLOGICS CO.,LTD.12.95%52 329
BIOGEN INC.22.60%44 738
ALEXION PHARMACEUTICALS, INC.0.00%40 336